Loading clinical trials...
Loading clinical trials...
Investigation of the Effects of Gastrocnemius Muscle Fatigue on Muscle Elastic Properties and Jump Performance
This study investigates the acute and 24-hour recovery effects of localized muscle fatigue on the viscoelastic properties of the medial gastrocnemius (MG) muscle and vertical jump performance. The research aims to quantify the changes in muscle stiffness, tone, and elasticity immediately after a standardized fatigue protocol and to monitor the recovery of these parameters 24 hours later. Additionally, the study evaluates the impact of fatigue on explosive power, measured by countermovement jump (CMJ) height, across these time points.
Participants undergo a structured experimental procedure to evaluate the changes across three time points: Baseline Assessment: Passive muscle tone (Hz), stiffness (N/m), and elasticity (logarithmic decrement) of the medial gastrocnemius (MG) are measured using the MyotonPRO device. Initial vertical jump height is determined through countermovement jump (CMJ) tests. Fatigue Protocol \& Acute Assessment: Participants perform standardized standing calf raises until task failure. Immediately following the protocol, MG myotonometric properties and CMJ performance are re-measured to determine the acute fatigue-induced changes. 24-Hour Follow-up: Participants return to the laboratory exactly 24 hours later. All measurements (MyotonPRO and CMJ) are repeated to assess the return to baseline levels and the recovery status of the muscle-tendon unit. The statistical analysis focuses on the differences between baseline, post-fatigue, and 24-hour recovery measurements.
Age
18 - 25 years
Sex
ALL
Healthy Volunteers
Yes
Istanbul Beykent University
Istanbul, Turkey (Türkiye)
Start Date
January 15, 2026
Primary Completion Date
February 15, 2026
Completion Date
February 24, 2026
Last Updated
March 9, 2026
28
ACTUAL participants
Isometric Plantar Flexion Fatigue Protocol
OTHER
Lead Sponsor
University of Beykent
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05013255